Protect Patients from Costly Care Act

HR 5094, the "Protect Patients from Costly Care Act," repeals two specific provisions from a prior reconciliation law (Public Law 119-21) that would have increased patient costs. It restores Medicaid cost sharing rules to their pre-2023 state, directly affecting Medicaid beneficiaries by preventing higher out-of-pocket costs. It also reverses changes to orphan drug exclusions under the Drug Price Negotiation Program, bringing those medications back under federal price negotiation rules for manufacturers. The bill does not create new policies but undoes specific cost-increasing changes to existing programs.